Stay updated on NIVO-IPI-TAXANE in Metastatic NSCLC Clinical Trial
Sign up to get notified when there's something new on the NIVO-IPI-TAXANE in Metastatic NSCLC Clinical Trial page.

Latest updates to the NIVO-IPI-TAXANE in Metastatic NSCLC Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision updated to v3.5.0; prior revision v3.4.3 was removed.SummaryDifference0.1%

- Check18 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. This appears to be a metadata/versioning update and does not affect trial details or user-facing content.SummaryDifference0.1%

- Check25 days agoNo Change Detected
- Check47 days agoChange DetectedAdded Revision: v3.4.2; removed the government funding lapse notice and the previous Revision: v3.4.1 entry. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check54 days agoChange DetectedAdded a site-wide government funding notice and a page revision tag (v3.4.1). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check61 days agoChange DetectedNew additions include a glossary display and status indicators such as 'Results First Posted' and 'Last Update Posted'. The page also removes older fields (e.g., 'Results First Posted (Estimated)', 'Last Update Submitted that met QC Criteria', 'Last Update Posted (Estimated)', and 'No FEAR Act data') and updates the revision to v3.4.0.SummaryDifference0.3%

- Check75 days agoChange DetectedRevision tag v3.3.4 has been added and revision tag v3.3.3 has been removed.SummaryDifference0.1%

Stay in the know with updates to NIVO-IPI-TAXANE in Metastatic NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NIVO-IPI-TAXANE in Metastatic NSCLC Clinical Trial page.